Theophylline for unexplained dyspnea in palliative medicine: A case report

Journal of Palliative Medicine

Volumn 11, Issue 3, 2008, Pages 510-513

  Kauser, Fariha ^a   LeGrand, Susan B ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BRONCHODILATING AGENT; DEXAMETHASONE; DEXTROPROPOXYPHENE; DIETHYLSTILBESTROL; HYDROCORTISONE; LAXATIVE; LORAZEPAM; METHYLPHENIDATE; METOCLOPRAMIDE; MORPHINE; PC SPES; PROSTATE SPECIFIC ANTIGEN; STEROID; THEOPHYLLINE;

ABSENCE OF SIDE EFFECTS; AGED; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DYSPNEA; GYNECOMASTIA; HUMAN; LUNG FUNCTION TEST; MALE; MORNING DOSAGE; OUTPATIENT CARE; OXYGEN SATURATION; PROSTATE CANCER; RADIATION DOSE; THORAX RADIOGRAPHY;

AGED; BRONCHODILATOR AGENTS; DYSPNEA; HUMANS; MALE; PALLIATIVE CARE; PROSTATIC NEOPLASMS; THEOPHYLLINE;

EID: 41149181164     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.9950     Document Type: Article

References (25)

1. Muers, MF, Rounds CE: Palliation of symptoms in non small-cell cancer: A study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 1993;48:339-343.
2. Donnelly S, Walsh D: The symptoms of advanced cancer. Semin Oncol 1995,22:72-76.
3. Reuben DB, Mor V: Dyspnea in terminally ill cancer patients. Chest 1986;89:234-236.
4. LeGrand SB: Dyspnea: The continuing challenge of palliative management. Curr Opin Oncol 2002:394-398.
5. Corner J, Plant H, A'hern R, Bailey C: Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med 1996;10:299-305.
6. de Graeff A, Dean M: Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards. J Palliat Med 2007;10:67-85.
7. Gift AG, Narsavage G: Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998;7:200-204.
8. Dudgeon D, Lertzman M: Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998;16:212-219.
9. Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J: The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000;19:357-362.
10. Jennings AL, Davies AN, Higgins JPT, Broadley K: Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev 2006;4:1-27.
11. Bruera E. Sala R. Spruyt O. Palmer JL. Zhang T. Willey J: Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study J Pain Symptom Manage 2005;29:613-618.
12. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnea. BMJ 2003;327:523-528.
13. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ: Morphine for the relief of breathlessness in patients with chronic heart failure - A pilot study. Eur J Heart Failure 2002;4:753-756.
14. Ripamonti C: Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7:233-243.
15. Higginson I, McCarthy M: Measuring symptoms in terminal cancer: Are pain and dyspnoea controlled? J R Soc Med 1989;82:264-267.
16. Dudgeon DJ, Lertzman M, Askew GR: Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage 2001;21:373-379.
17. Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J: Effects of oxygen on dyspnea in hypoxemic terminal-cancer patients. Lancet 1993;342:13-14.
18. Philip J, Gold M, Milner A, Di Iulio J, Miller B, Spruyt O: A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage 2006;32:541-550.
19. Gallagher R, Roberts D: A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. J Pain Palliat Care Pharmacother 2004;18:3-15.
20. Landsberg KF, Vaughan LM, Heffner JE: The effect of of theophylline on respiratory muscle contractility and fatigue. Pharmacotherapy 1990;10;271-279.
21. Hendeles L, Weinberger M: Theophylline, a state of the art review. Pharmacotherapy 1983;3:2-44.
22. Mahler D, Matthay RA, Snyder PE, Wells CK, Loke J: Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis 1985;131:22-25.
23. Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadden ER Jr: Emergency therapy of asthma: Comparison of acute effects of parenteral sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980;122:365-371.
24. Murciano D, Aubier M, Lecocguic V, Pariente R: Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive lung disease. N Engl J Med 1984;311:349-353.
25. Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C: Aminophylline improves diaphragmatic contractility. N Engl J Med 1981;305:249-252.